Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00JCA
|
|||
| Former ID |
DIB014503
|
|||
| Drug Name |
NewGam
|
|||
| Indication | Immune System disease [ICD-11: 4A01-4B41; ICD-10: D80-D89] | Phase 3 | [1] | |
| Company |
Octapharma AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01012323) Clinical Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Patients With Primary Immunodeficiency Diseases. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.